Matching the pathology report of the patient tumor, but even more so of the PDX, HROP68Tu2 cells showed homogeneous and high PD-L1 expression (95.9% ± 2.2, MFI: 26.5 ± 0.8). The gene discussed is CD274; the disease is neoplasm.